Pittala, S.;                     Levy, I.;                     De, S.;                     Kumar Pandey, S.;                     Melnikov, N.;                     Hyman, T.;                     Shoshan-Barmatz, V.    
        The VDAC1-based R-Tf-D-LP4 Peptide as a Potential Treatment for Diabetes Mellitus. Cells 2020, 9, 481.
    https://doi.org/10.3390/cells9020481
    AMA Style
    
                                Pittala S,                                 Levy I,                                 De S,                                 Kumar Pandey S,                                 Melnikov N,                                 Hyman T,                                 Shoshan-Barmatz V.        
                The VDAC1-based R-Tf-D-LP4 Peptide as a Potential Treatment for Diabetes Mellitus. Cells. 2020; 9(2):481.
        https://doi.org/10.3390/cells9020481
    
    Chicago/Turabian Style
    
                                Pittala, Srinivas,                                 Idan Levy,                                 Soumasree De,                                 Swaroop Kumar Pandey,                                 Nataly Melnikov,                                 Tehila Hyman,                                 and Varda Shoshan-Barmatz.        
                2020. "The VDAC1-based R-Tf-D-LP4 Peptide as a Potential Treatment for Diabetes Mellitus" Cells 9, no. 2: 481.
        https://doi.org/10.3390/cells9020481
    
    APA Style
    
                                Pittala, S.,                                 Levy, I.,                                 De, S.,                                 Kumar Pandey, S.,                                 Melnikov, N.,                                 Hyman, T.,                                 & Shoshan-Barmatz, V.        
        
        (2020). The VDAC1-based R-Tf-D-LP4 Peptide as a Potential Treatment for Diabetes Mellitus. Cells, 9(2), 481.
        https://doi.org/10.3390/cells9020481